MENU

INDP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Indaptus Therapeutics (INDP) Ownership - Who owns Indaptus Therapeutics?

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

3 Columbus Circle 15th Floor

Phone

+1 646 427-2727

Employees

5

Web

https://www.indaptusrx.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

407.72M

P/E Ratio

N/A

Total Cash

1.5M

Projected Growth

N/A

Total Debt

8.69K

Revenue

N/A

Risk (Beta)

1.45

Dividend Yield

N/A

Total Cash/Share

0.01

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

INDP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for INDP

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details

Industry

N/A

Address

3 Columbus Circle 15th Floor

Phone

+1 646 427-2727

Employees

5

Web

https://www.indaptusrx.com